IndraLab

Statements

MAPK1 phosphorylates RPS6KB1 on S447. 5 / 5
1 4 |
signor
"Erk phosphorylates multiple cytoplasmatic and cytoskeletal proteins, including mapk-activated protein kinases and the ribosomal p70-s6 kinase"
21035469
signor
"Erk phosphorylates multiple cytoplasmatic and cytoskeletal proteins, including mapk-activated protein kinases and the ribosomal p70-s6 kinase"
14967450
signor
"Erk phosphorylates multiple cytoplasmatic and cytoskeletal proteins, including mapk-activated protein kinases and the ribosomal p70-s6 kinase"
7545671
biopax:phosphositeplus
No evidence text available
signor
"Erk phosphorylates multiple cytoplasmatic and cytoskeletal proteins, including mapk-activated protein kinases and the ribosomal p70-s6 kinase."
19085255
MAPK1 phosphorylates RPS6KB1 on S434. 5 / 5
1 4 |
biopax:phosphositeplus
No evidence text available
signor
"Erk phosphorylates multiple cytoplasmatic and cytoskeletal proteins, including mapk-activated protein kinases and the ribosomal p70-s6 kinase"
14967450
signor
"Erk phosphorylates multiple cytoplasmatic and cytoskeletal proteins, including mapk-activated protein kinases and the ribosomal p70-s6 kinase"
7545671
signor
"Erk phosphorylates multiple cytoplasmatic and cytoskeletal proteins, including mapk-activated protein kinases and the ribosomal p70-s6 kinase"
21035469
signor
"Erk phosphorylates multiple cytoplasmatic and cytoskeletal proteins, including mapk-activated protein kinases and the ribosomal p70-s6 kinase."
19085255
MAPK1 phosphorylates RPS6KB1 on T444. 3 / 3
1 2 |
biopax:phosphositeplus
No evidence text available
signor
"The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain."
11705993
signor
"The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain."
15774499
MAPK1 phosphorylates RPS6KB1-S6K. 1 / 1
| 1
reach
"Erk-2 does not directly phosphorylate p70 S6K in vitro [28]."
9202140